deguelin has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Belofsky, G; Brown, M; Cardenas-Garcia, B; Chen, X; Deardorff, K; Dondji, B; Ferreira, D; Fulkerson, S; Gény, C; Jones, K; McCornack, J; McNutt, S; Ray, W; Winterstein, E | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Feng, B; Mu, J; Qi, W; Tang, JY; Wei, Y; Wu, Q; Yang, LL; Zeng, W; Zhang, Q | 1 |
| Chen, K; Chen, L; Li, S; Li, Y; Liu, Z; Long, C; Peng, A; Tang, H; Tang, M; Wu, W; Xiang, M; Xie, C; Yang, J; Ye, H | 1 |
| Vargas Núñez, JA | 1 |
| Boyd, J; Han, A | 1 |
| Caboni, P; Casida, JE; Greenamyre, JT; Na, HM; Sherer, TB; Taylor, G; Zhang, N | 1 |
| Lubet, RA; Tan, Q; Wang, Y; Yan, Y; You, M | 1 |
| Kim, JH; Kim, KW; Lee, HY; Shin, JY; Yu, YS | 1 |
1 review(s) available for deguelin and Disease Models, Animal
| Article | Year |
|---|---|
Deguelin and Its Role in Chronic Diseases.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Chronic Disease; Disease Models, Animal; Drug Discovery; Electron Transport Complex I; Enzyme Inhibitors; Humans; Molecular Structure; Parkinson Disease, Secondary; Phytotherapy; Plants, Medicinal; Risk Factors; Rotenone; Signal Transduction | 2016 |
8 other study(ies) available for deguelin and Disease Models, Animal
| Article | Year |
|---|---|
Phenolic Metabolites of Dalea ornata Affect Both Survival and Motility of the Human Pathogenic Hookworm Ancylostoma ceylanicum.
Topics: Albendazole; Ancylostoma; Ancylostomatoidea; Ancylostomiasis; Animals; Anthelmintics; Cricetinae; Disease Models, Animal; Disease Resistance; Fabaceae; Humans; Mebendazole; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phenols; Plant Components, Aerial; Rosaceae; Saxifragaceae; Spleen | 2016 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Mesangium; Glucose; Humans; Inflammation; Inflammation Mediators; Kidney; Leupeptins; Male; Mesangial Cells; Proteasome Inhibitors; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Rotenone; Signal Transduction | 2019 |
Millettia pachycarpa exhibits anti-inflammatory activity through the suppression of LPS-induced NO/iNOS expression.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cells, Cultured; Depression, Chemical; Disease Models, Animal; Edema; Flavones; Flavonoids; Lipopolysaccharides; Macrophages; Male; Mice, Inbred ICR; Millettia; Nitric Oxide; Nitric Oxide Synthase Type II; Phytotherapy; Rotenone; Seeds | 2014 |
[SYNERGISTIC ACTIVITY OF DEGUELIN AND FLUDARABINE IN PRIMARY CELLS FROM CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS (CLL) AND IN A CLL MURINE MODEL].
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Disease Models, Animal; Drug Synergism; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Middle Aged; Primary Cell Culture; Rotenone; Tumor Cells, Cultured; Vidarabine | 2014 |
Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
Topics: Animals; Brain Chemistry; Cells, Cultured; Chromatography, High Pressure Liquid; Corpus Striatum; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Infusion Pumps, Implantable; Injections, Subcutaneous; Insecticides; Liver; Male; Parkinson Disease; Rats; Rats, Inbred Lew; Rotenone; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Substantia Nigra; Uncoupling Agents | 2004 |
Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.
Topics: Adenoma; Administration, Oral; Animals; Benzo(a)pyrene; Disease Models, Animal; Lung Neoplasms; Mice; Mice, Inbred A; Rotenone; Silybin; Silybum marianum; Silymarin | 2005 |
Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Down-Regulation; Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infant, Newborn; Mice; Mice, Inbred C57BL; Oxygen; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Rotenone | 2008 |